tiprankstipranks

Steven Keith Burke Insider Profile

4 Followers
Steven Keith Burke, SVP and Chief Medical Officer at Protara Therapeutics, holds 668.84K shares in Akebia Therapeutics (Ticker: AKBA), holds 128.25K shares in Protara Therapeutics (Ticker: TARA). Most recently, Steven Keith Burke Sold ― shares of Akebia Therapeutics on May 09, 2024 for an estimated value of 31.05K.
tipranks
Steven Keith Burke

Steven Keith Burke
Protara Therapeutics (TARA)
SVP and Chief Medical Officer

Ranked #73,688 out of 99,335 Corporate Insiders

Profitable Transactions

27%
3 out of 11 Profitable Transactions

Average Return

-9.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
80.56%
19.44%
A breakdown of Steven Keith Burke's holdings

Insider Roles

Akebia Therapeutics
(AKBA)
SVP, Chief Medical Officer
Protara Therapeutics
(TARA)
SVP and Chief Medical Officer
Roles that Steven Keith Burke holds in companies

Most Profitable Insider Trade

Stock:
Akebia Therapeutics
(AKBA)
Rating:Informative Sell
Date:Apr 01, 2021 - Apr 01, 2022
Return:+79.90%
The most profitable trade made by Steven Keith Burke

Steven Keith Burke's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Protara Therapeutics
Mar 18, 2019
SVP and Chief Medical Officer
Uninformative Buy
$293.69K
Akebia Therapeutics
May 09, 2024
SVP, Chief Medical Officer
Informative Sell
31.05K
$1.22M
List of latest transactions for each holding click on a transaction to see Steven Keith Burke's performance on stock

Steven Keith Burke insider profile FAQ

What is the percentage of profitable transactions made by Steven Keith Burke?
The percentage of profitable transactions made by Steven Keith Burke is 27%.
    What is the average return per transaction made by Steven Keith Burke?
    The average return per transaction made by Steven Keith Burke is -9.90%.
      What stocks does Steven Keith Burke hold?
      Steven Keith Burke holds: TARA, AKBA stocks.
        What was Steven Keith Burke’s latest transaction?
        Steven Keith Burke latest transaction was an Informative Sell of $31.05K.
          What was Steven Keith Burke's most profitable transaction?
          Steven Keith Burke’s most profitable transaction was an Informative Sell of AKBA stock on April 1, 2021. The return on the trade was 79.90%.
            What is Steven Keith Burke's role in Protara Therapeutics?
            Steven Keith Burke's role in Protara Therapeutics is SVP and Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.